- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06808568
Expanded Access Program (EAP) STIMULAN VG (EAPSTIMVG)
Study Overview
Status
Intervention / Treatment
Detailed Description
Patients facing serious or life-threatening illnesses who have exhausted currently available treatment options and are ineligible or unable to participate in a clinical trial may decide to explore therapeutic use of investigational drugs with their healthcare providers.
Under these circumstances, single-patient access can be requested from a licensed treating physician on behalf of the patient.
Please contact expandedaccess@biocomposites.com for more information.
Study Type
Expanded Access Type
- Individual Patients
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
-
Exclusion Criteria:
-
Study Plan
How is the study designed?
Collaborators and Investigators
Sponsor
Study record dates
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EAPSTIMVG
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.